Retinoic acid isomers applied to human skin in vivo each induce a 4-hydroxylase that inactivates only trans retinoic acid

被引:38
作者
Duell, EA [1 ]
Kang, S [1 ]
Voorhees, JJ [1 ]
机构
[1] UNIV MICHIGAN,SCH MED,DEPT DERMATOL,ANN ARBOR,MI
关键词
metabolism; isomerization; pharmacology; cytochrome;
D O I
10.1111/1523-1747.ep12342972
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Application of all-trans retinoic acid to human skin for 4 d under occlusion produces a marked increase in retinoic acid 4-hydroxylase activity. In this study, the possible induction of other hydroxylases in response to 9-cis and 13-cis retinoic acid applications to adult human skin in vivo was determined. Application of 0.1% all-trans, 0.1% 9-cis, and 0.1% 13-cis retinoic acid to human skin for 2 d resulted in induction of only all-trans retinoic acid 4-hydroxylase activity. The 4-hydroxylase activity in microsomes from the treated tissue ranged from 383 +/- 46 to 531 +/- 59 pg of 4-hydroxy all-trans retinoic acid formed/min/mg protein (n = 6). These same preparations were unable to use 9-cis or 13-cis retinoic acid as substrate for the hydroxylation reaction. Extraction of the retinoic acid isomers from epidermis 48 h after application of 0.1% solution of each isomer yielded significant amounts of all-trans retinoic acid (36-72%) regardless of the isomer applied. The all-trans isomer produced by isomerization of both 9-cis and 13-cis retinoic acids is the likely inducer of the 4-hydroxylase. All-trans retinol and all-trans retinal were unable to compete with all-trans retinoic acid as substrate for 4-hydroxylase enzyme. The 4-hydroxylase induced in response to pharmacological doses of retinoic acids is specific for the all-trans isomer. The inability of 9-cis or 13-cis retinoic acid to induce their own hydroxylation and inactivation or act as substrate for the 4-hydroxylase in skin may have considerable implications in light of the clinical use of retinoids in the treatment of various diseases including cancers.
引用
收藏
页码:316 / 320
页数:5
相关论文
共 15 条
[1]   REPEATED TOPICAL ADMINISTRATION OF ALL-TRANS-RETINOIC ACID AND PLASMA-LEVELS OF RETINOIC ACIDS IN HUMANS [J].
BUCHAN, P ;
ECKHOFF, C ;
CARON, D ;
NAU, H ;
SHROOT, B ;
SCHAEFER, H .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (03) :428-434
[2]   DETERMINATION OF ISOTRETINOIN OR ETRETINATE AND THEIR MAJOR METABOLITES IN HUMAN-BLOOD BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BUGGE, CJL ;
RODRIGUEZ, LC ;
VANE, FM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1985, 3 (03) :269-277
[3]  
CASTAIGNE S, 1993, BLOOD, V82, P3560
[4]   HUMAN SKIN LEVELS OF RETINOIC ACID AND CYTOCHROME P-450-DERIVED 4-HYDROXYRETINOIC ACID AFTER TOPICAL APPLICATION OF RETINOIC ACID INVIVO COMPARED TO CONCENTRATIONS REQUIRED TO STIMULATE RETINOIC ACID RECEPTOR-MEDIATED TRANSCRIPTION INVITRO [J].
DUELL, EA ;
ASTROM, A ;
GRIFFITHS, CEM ;
CHAMBON, P ;
VOORHEES, JJ .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1269-1274
[5]   THE NEGLIGIBLE SYSTEMIC AVAILABILITY OF RETINOIDS WITH MULTIPLE AND EXCESSIVE TOPICAL APPLICATION OF ISOTRETINOIN 0.05-PERCENT GEL (ISOTREX) IN PATIENTS WITH ACNE-VULGARIS [J].
JENSEN, BK ;
MCGANN, LA ;
KACHEVSKY, V ;
FRANZ, TJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 24 (03) :425-428
[6]  
KALIN JR, 1984, DRUG METAB DISPOS, V12, P63
[7]   APPLICATION OF RETINOL TO HUMAN SKIN IN-VIVO INDUCES EPIDERMAL HYPERPLASIA AND CELLULAR RETINOID-BINDING PROTEINS CHARACTERISTIC OF RETINOIC ACID BUT WITHOUT MEASURABLE RETINOIC ACID LEVELS OR IRRITATION [J].
KANG, SW ;
DUELL, EA ;
FISHER, GJ ;
DATTA, SC ;
WANG, ZQ ;
REDDY, AP ;
TAVAKKOL, A ;
YI, JY ;
GRIFFITHS, CEM ;
ELDER, JT ;
VOORHEES, JJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (04) :549-556
[8]   METABOLISM OF RETINOL AND RETINOIC ACID BY HUMAN-LIVER CYTOCHROME-P450IIC8 [J].
LEO, MA ;
LASKER, JM ;
RAUCY, JL ;
KIM, CI ;
BLACK, M ;
LIEBER, CS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1989, 269 (01) :305-312
[9]  
LIPPMAN SM, 1994, CANCER RES, V54, pS2025
[10]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265